16-10-2012, 01:49 PM
Assignment – I A Study on Cipla Ltd
Cipla Ltd.docx (Size: 216.56 KB / Downloads: 82)
Ownership
Khwaja Abdul Hamied, the founder of Cipla in 1935, he set up the chemical, Industrial & Pharmaceutical Laboratories, which came to be popularly known as Cipla.
Promoter shares are 34.3% & public share holding is 62.7%.
Vision & Mission Statement
Vision: To heal india and to become the biggest and the most admired pharmaceutical company in india.
Mission: Cipla commits itself to endeavour to satisfy our customers' needs in every manner possible: through excellent service, by developing and marketing an effective, safe, quality product and by offering our product at a price affordable to all patients.
People in the Organization
Over 16000 employees work in the company.
Management practiced at the Company
All directors and senior management employees of the Company ensure that their actions in the conduct of business are totally transparent except where the needs of business security dictate otherwise. Such transparency shall be brought about through appropriate policies, systems and processes.
Culture of the Organization
Any director or senior management employee of the Company shall not engage in any business, relationship or activity, which might detrimentally conflict with the interest of the Company. All directors and senior management employees of the Company shall ensure that their actions in the conduct of business are totally transparent except where the needs of business security dictate otherwise. Such transparency shall be brought about through appropriate policies, systems and processes.
Sustainable Strategy
Strong Product Pipeline: The Company has secured 170 marketing authorizations in Europe, 4000 product registrations globally and 7000 pending approvals.
Ethical Values
All directors and senior management employees shall deal on behalf of the Company with professionalism, honesty, integrity as well as high moral and ethical standards. Such conduct shall be fair and transparent and be perceived to be as such by third parties.
Major Changes
Cipla has a robust portfolio of vanilla and difficult-toproduce generics that it can offer MNCs who want to grow in emerging markets. "If I don't, there are 20 other Indian companies who will," agrees Dr Hamied. The bigger challenge to this business is the change in the drug patents law that prevents companies from reverse-engineering patented drugs. Cipla has taken the high road. Using provisions of this law, it has overturned innovator patents in Indian courts. But this comes at a cost - Rs 15-20 crore in legal fees last year, says Dr Hamied. Analysts would like to see Cipla forge marketing partnerships in India with patent-holders for new drugs like Sun or Zydus Cadila.
Growth&Future prospects
Cipla Ltd reported a net profit of Rs 291.74 crore for the quarter ended March 31, 2012, compared to Rs 214 crore for the quarter ended March 31, 2011. The company posted a net profit of Rs 1,123.96 crore for the year ended March 31, 2012, compared to Rs 960.39 crore in the previous year.
Total income increased to Rs 7,125.80 crore for the year ended March 31, 2012, from Rs 6,422.29 crore for the year ended March 31, 2011.
Pharma major cipla plans to invest Rs 500 crore for setting up active pharmaceutical ingredients (API) facilities at Patalganga, Bengaluru and Kurkumbh.
My thought about the Company
Cipla is one of the top pharmaceuticals company in India. Cipla that uses the latest pharmaceutical Technology to funnel over seven decades of experience in to one capsule cures,one drop that defends and one puff that protects. Cipla explore every drug to its particle and instill safe and sure healing to create one dose of confidence, for us the final measure our success is a simple curve the smile of health regained.Today cipla continue to work tirelessly to realize their founder’s vision of providing quality medicine at affordable prices.